Prevalence of Psychiatric Disorders in the Refugee Population of Turkey

December 9, 2021 updated by: Suleyman Keles, MD, Kutahya Health Sciences University
The investigators are planning to diagnose psychiatric disorders in willing participants from the refugee population in Turkey.

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Kütahya, Turkey, 43100
        • Kutahya Health Sciences University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Outpatients in a primary care clinic who have official refugee status

Description

Inclusion Criteria:

  • Having official refugee status in Turkey, willing to participate in the study

Exclusion Criteria:

  • Having any disability that prevents answering interviewers' questions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Any diagnosed psychiatric disorder using the Mini-International Neuropsychiatric Interview
Time Frame: Through study completion, on average five months
The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview designed to screen for DSM-5 and ICD-10 psychiatric disorders. It will be utilized on willing participants from Turkey's refugee population.
Through study completion, on average five months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kutahya Health Sciences University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 9, 2021

Primary Completion (ACTUAL)

December 9, 2021

Study Completion (ACTUAL)

December 9, 2021

Study Registration Dates

First Submitted

September 25, 2021

First Submitted That Met QC Criteria

October 9, 2021

First Posted (ACTUAL)

October 21, 2021

Study Record Updates

Last Update Posted (ACTUAL)

December 13, 2021

Last Update Submitted That Met QC Criteria

December 9, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1 (Other Identifier: Mobile Health and Wellness Program)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychiatric Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe